Literature DB >> 35022204

Hallmarks of Cancer: New Dimensions.

Douglas Hanahan1.   

Abstract

The hallmarks of cancer conceptualization is a heuristic tool for distilling the vast complexity of cancer phenotypes and genotypes into a provisional set of underlying principles. As knowledge of cancer mechanisms has progressed, other facets of the disease have emerged as potential refinements. Herein, the prospect is raised that phenotypic plasticity and disrupted differentiation is a discrete hallmark capability, and that nonmutational epigenetic reprogramming and polymorphic microbiomes both constitute distinctive enabling characteristics that facilitate the acquisition of hallmark capabilities. Additionally, senescent cells, of varying origins, may be added to the roster of functionally important cell types in the tumor microenvironment. SIGNIFICANCE: Cancer is daunting in the breadth and scope of its diversity, spanning genetics, cell and tissue biology, pathology, and response to therapy. Ever more powerful experimental and computational tools and technologies are providing an avalanche of "big data" about the myriad manifestations of the diseases that cancer encompasses. The integrative concept embodied in the hallmarks of cancer is helping to distill this complexity into an increasingly logical science, and the provisional new dimensions presented in this perspective may add value to that endeavor, to more fully understand mechanisms of cancer development and malignant progression, and apply that knowledge to cancer medicine. ©2021 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2022        PMID: 35022204     DOI: 10.1158/2159-8290.CD-21-1059

Source DB:  PubMed          Journal:  Cancer Discov        ISSN: 2159-8274            Impact factor:   39.397


  351 in total

1.  Bee venom protects against pancreatic cancer via inducing cell cycle arrest and apoptosis with suppression of cell migration.

Authors:  Jing Zhao; Weiguo Hu; Zejia Zhang; Zegao Zhou; Jiayue Duan; Zheng Dong; Hao Liu; Changqing Yan
Journal:  J Gastrointest Oncol       Date:  2022-04

Review 2.  Oncogenic functions of the FOXC2 transcription factor: a hallmarks of cancer perspective.

Authors:  Kristian M Hargadon; Travis B Goodloe; Nathaniel D Lloyd
Journal:  Cancer Metastasis Rev       Date:  2022-06-14       Impact factor: 9.264

Review 3.  Applications of artificial intelligence multiomics in precision oncology.

Authors:  Ruby Srivastava
Journal:  J Cancer Res Clin Oncol       Date:  2022-07-07       Impact factor: 4.553

Review 4.  Message in the bottle: regulation of the tumor microenvironment via exosome-driven proteolysis.

Authors:  Agathe Quesnel; Amy Broughton; George S Karagiannis; Panagiota S Filippou
Journal:  Cancer Metastasis Rev       Date:  2022-04-08       Impact factor: 9.264

Review 5.  Stem Cells in the Tumor Immune Microenvironment -Part of the Cure or Part of the Disease? Ontogeny and Dichotomy of Stem and Immune Cells has Led to better Understanding.

Authors:  Cosmin Andrei Cismaru; Radu Pirlog; George Adrian Calin; Ioana Berindan-Neagoe
Journal:  Stem Cell Rev Rep       Date:  2022-07-16       Impact factor: 6.692

6.  Antitumor activity of mianserin (a tetracyclic antidepressant) primarily driven by the inhibition of SLC1A5-mediated glutamine transport.

Authors:  Zelin Duan; Zhiyun Zhou; Feifei Lu; Yawen Zhang; Xvqin Guo; Chunshan Gui; Hongjian Zhang
Journal:  Invest New Drugs       Date:  2022-07-14       Impact factor: 3.651

7.  Mapping Phenotypic Plasticity upon the Cancer Cell State Landscape Using Manifold Learning.

Authors:  John G Lock; Smita Krishnaswamy; Christine L Chaffer; Daniel B Burkhardt; Beatriz P San Juan
Journal:  Cancer Discov       Date:  2022-08-05       Impact factor: 38.272

8.  PRC2 Heterogeneity Drives Tumor Growth in Medulloblastoma.

Authors:  Jiaqing Yi; BongWoo Kim; Xuanming Shi; Xiaoming Zhan; Q Richard Lu; Zhenyu Xuan; Jiang Wu
Journal:  Cancer Res       Date:  2022-08-16       Impact factor: 13.312

Review 9.  Triple negative breast cancer (TNBC): Non-genetic tumor heterogeneity and immune microenvironment: Emerging treatment options.

Authors:  Jae Young So; Joyce Ohm; Stan Lipkowitz; Li Yang
Journal:  Pharmacol Ther       Date:  2022-07-21       Impact factor: 13.400

10.  How epigenomics broke the mold: an interview with Peter W Laird.

Authors:  Peter W Laird
Journal:  Epigenomics       Date:  2022-03-24       Impact factor: 4.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.